Form 15-12G - Securities registration termination [Section 12(g)]:
SEC Accession No. 0001140361-24-009374
Filing Date
2024-02-26
Accepted
2024-02-26 09:00:55
Documents
1
Effectiveness Date
2024-02-26

Document Format Files

Seq Description Document Type Size
1 15-12G ny20021647x4_1512g.htm 15-12G 11417
  Complete submission text file 0001140361-24-009374.txt   12465
Mailing Address 314 MAIN STREET, SUITE 04-200 CAMBRIDGE MA 02142
Business Address 314 MAIN STREET, SUITE 04-200 CAMBRIDGE MA 02142 (857) 400-9491
Theseus Pharmaceuticals, Inc. (Filer) CIK: 0001745020 (see all company filings)

EIN.: 830712806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 15-12G | Act: 34 | File No.: 001-40869 | Film No.: 24673777
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)